首页 | 本学科首页   官方微博 | 高级检索  
     

单中心心脏再同步治疗相关并发症分析
引用本文:秦付超,周贤惠,邢强,李耀东,张疆华,芦颜美,祖克拉·,吐尔洪,杨徐,汤宝鹏. 单中心心脏再同步治疗相关并发症分析[J]. 中华心脏与心律电子杂志, 2022, 10(3): 141-146. DOI: 10.3877/cma.j.issn.2095-6568.2022.03.003
作者姓名:秦付超  周贤惠  邢强  李耀东  张疆华  芦颜美  祖克拉·  吐尔洪  杨徐  汤宝鹏
作者单位:1. 830054 乌鲁木齐,新疆医科大学第一附属医院心脏中心起搏电生理科 新疆心电生理与心脏重塑重点实验室
基金项目:新疆维吾尔自治区自然基金重点项目(2022D01D15)
摘    要:目的回顾性总结单中心心脏再同步治疗(CRT)相关并发症概况为临床对CRT患者的管理提供相关经验。 方法本研究为回顾性研究,纳入2009年6月至2021年6月在新疆医科大学第一附属医院心血管内科植入CRT的心力衰竭(心衰)患者,按照植入装置类型分为心脏再同步治疗除颤器(CRT-D)组和心脏再同步治疗起搏器(CRT-P)组,分析患者术中、术后发生左心室导线植入失败、膈肌刺激、冠状静脉系统损伤等相关并发症的情况及原因。 结果共纳入469例患者,其中男359例(359/469,76.55%),年龄(62.31±11.69)岁,术前左心室射血分数为34.76%±7.96%,术前QRS时限为(161.82±30.57)ms。左心室导线植入成功率为95.1%(446/499)。术中膈肌刺激2例(0.43%);急性左心衰竭3例(6.40%);冠状静脉夹层15例(3.19%);囊袋血肿4例(0.85%);导线脱位10例(2.13%),其中急性脱位2例(20%)、亚急性脱位4例(40%)、迟发性脱位4例(40%)。 结论CRT术中发生相关并发症的风险较高,同时也要警惕和排除发生相关术后并发症的可能。

关 键 词:心力衰竭  心脏再同步治疗  并发症  
收稿时间:2022-05-06

Analysis of complications associated with cardiac resynchronization therapy: single-center case analysis
Fuchao Qin,Xianhui Zhou,Qiang Xing,Yaodong Li,Jianghua Zhang,Yanmei Lu,Zukra,middot,Turhong,Xu Yang,Baopeng Tang. Analysis of complications associated with cardiac resynchronization therapy: single-center case analysis[J]. Chinese Journal of Heart and Heart Rhythm, 2022, 10(3): 141-146. DOI: 10.3877/cma.j.issn.2095-6568.2022.03.003
Authors:Fuchao Qin  Xianhui Zhou  Qiang Xing  Yaodong Li  Jianghua Zhang  Yanmei Lu  Zukra·  Turhong  Xu Yang  Baopeng Tang
Affiliation:1. Department of Pacing and Electrophysiology, Department of Cardiac Electrophysiology and Remodeling, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China
Abstract:ObjectiveTo retrospectively summarize the complications associated with cardiac resynchronization therapy (CRT) in a single center in order to provide relevant experience for the clinical management of CRT patients. MethodsThis study is a retrospective study. Patients with heart failure who underwent CRT implantation in the Department of Cardiovascular Medicine, The First Affiliated Hospital of Xinjiang Medical University from June 2009 to June 2021 were included. The patients were divided into cardiac resynchronization therapy defibrillator (CRT-D) and cardiac resynchronization therapy pacemaker (CRT-P) according to the type of implanted device. In the CRT-P group, the failure of left ventricular lead implantation, diaphragm muscle stimulation, coronary venous system injury and other related complications were analyzed, and the reasons for the complications were recorded. ResultsA total of 469 patients were enrolled, including 359 males (359/469, 76.55%), age (62.31±11.69) years, preoperative mean left ventricular ejection fraction was 34.76%±7.96%, preoperative mean QRS duration was (161.82±30.57) ms. The success rate of left ventricular lead implantation was 95.1% (446/499), intraoperative diaphragm stimulation in 2 cases (0.43%); acute left heart failure in 3 cases (6.40%); coronary vein dissection in 15 cases (3.19%). Hematoma occurred in 4 cases (0.85%), and lead dislocation in 10 cases (2.13%), including acute dislocation in 2 cases (20%), subacute dislocation in 4 cases (40%), and delayed dislocation in 4 cases (40%). ConclusionThe risk of complications related to CRT is high, and at the same time, we should be alert and rule out the possibility of related postoperative complications.
Keywords:Heart failure  Cardiac resynchronization therapy  Complication  
点击此处可从《中华心脏与心律电子杂志》浏览原始摘要信息
点击此处可从《中华心脏与心律电子杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号